“HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer

BACKGROUND: Pancreatic cancer has a dismal prognosis with 5-year overall survival rate of around 5%. Although surgery is still the best option in operable cases, majority of the patients who present in locally advanced stages are deemed inoperable. Novel approaches are therefore needed for the manag...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Radiat Oncol
Главные авторы: Datta, Niloy Ranjan, Pestalozzi, Bernhard, Clavien, Pierre-Alain, Siebenhüner, Alexander, Puric, Emsad, Khan, Shaka, Mamot, Christoph, Riesterer, Oliver, Knuchel, Jürg, Reiner, Cäcilia Sophie, Bodis, Stephan
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2017
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698973/
https://ncbi.nlm.nih.gov/pubmed/29162142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0923-8
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы